K Aebert. Show Affiliations »
Abstract
Entities: Chemical Disease
Mesh: See more » AgedBiperiden/therapeutic useBlood-Brain BarrierDesipramine/therapeutic useDihydroxyphenylalanine/administration & dosageDopa Decarboxylase/metabolismFemaleHumansInfusions, ParenteralMaleMethyldopa/therapeutic useMiddle AgedParasympatholytics/therapeutic useParkinson Disease/complications
Substances: See more » ParasympatholyticsBiperidenMethyldopaDihydroxyphenylalanineDopa DecarboxylaseDesipramine
Year: 1967 PMID: 6019685 DOI: 10.1055/s-0028-1103669
Source DB: PubMed Journal: Dtsch Med Wochenschr ISSN: 0012-0472 Impact factor: 0.628